Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone-Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05509894
What this trial is testing

Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone

Who this might be right for
Pediatric Growth Hormone Deficiency
Pfizer 565
Not applicableStudy completedNCT01080755
What this trial is testing

Metabolic Endocrinology and Growth Hormone in Adults

Who this might be right for
Adult Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany 90
Large-scale testing (Phase 3)WithdrawnNCT00286676
What this trial is testing

The Use of Nutropin Depot in HIV-infected Adult Males

Who this might be right for
HIV Infection
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT00646815
What this trial is testing

Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
University of Aarhus 24
Not applicableStudy completedNCT03525587
What this trial is testing

Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Azienda Ospedaliero-Universitaria di Modena 83
Post-approval studies (Phase 4)Study completedNCT01806298
What this trial is testing

An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)

Who this might be right for
Adult Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany 78
Not applicableStudy completedNCT00006394
What this trial is testing

Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency

Who this might be right for
OsteoporosisGrowth Hormone Deficiency
National Center for Research Resources (NCRR) 72
Early research (Phase 1)UnknownNCT00473187
What this trial is testing

Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets

Who this might be right for
Hypophosphatemic RicketsGrowth DisordersSomatropin Therapy
University of Rostock
Testing effectiveness (Phase 2)Ended earlyNCT00490100
What this trial is testing

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

Who this might be right for
Growth FailureX-linked Severe Combined Immunodeficiency (XSCID)Growth Hormone Resistence
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)UnknownNCT00271518
What this trial is testing

Treatment of Children With Insufficient Secretion of Growth Hormone

Who this might be right for
Growth Hormone Deficiency (GHD)
LG Life Sciences 144
Large-scale testing (Phase 3)Study completedNCT02339090
What this trial is testing

Long-Acting Growth Hormone in Children Compared to Daily rhGH

Who this might be right for
Growth Disorders
Versartis Inc. 138
Testing effectiveness (Phase 2)Study completedNCT01811576
What this trial is testing

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Teva Branded Pharmaceutical Products R&D, Inc. 52
Early research (Phase 1)Study completedNCT01775358
What this trial is testing

Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Who this might be right for
Growth Hormone Deficiency
Aileron Therapeutics, Inc. 33
Not applicableStudy completedNCT00616278
What this trial is testing

National Cooperative Growth Study in CKD

Who this might be right for
Growth Hormone Deficiency
University of California, Davis 27
Testing effectiveness (Phase 2)Study completedNCT02500316
What this trial is testing

Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Who this might be right for
Growth Hormone Deficiency (GHD)
OPKO Health, Inc. 48
Large-scale testing (Phase 3)Study completedNCT00190658
What this trial is testing

Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome

Who this might be right for
Failure to Thrive
Eli Lilly and Company 75
Not applicableStudy completedNCT03826160
What this trial is testing

Growth Hormone Dynamics and Cardiac Steatosis in HIV

Who this might be right for
Human Immunodeficiency VirusLipodystrophyCardiac Disease
Massachusetts General Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT02719990
What this trial is testing

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Who this might be right for
Adult Growth Hormone Deficiency (AGHD)
Versartis Inc. 36
Not applicableStudy completedNCT00562796
What this trial is testing

Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity

Who this might be right for
ObesityGrowth Hormone
Massachusetts General Hospital 149
Testing effectiveness (Phase 2)Study completedNCT00004340
What this trial is testing

Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis

Who this might be right for
Renal OsteodystrophyEnd Stage Renal Disease
National Center for Research Resources (NCRR) 109
Next Page